Follow Us
954-421-3200

Mohs Micrographic Surgery may have higher survival for invasive Melanomas on the Head and Neck

|Comments are Off
According to a study published in the Journal of the American Academy of Dermatology, patients who were treated with Mohs’ Micrographic Surgery had a higher 5-year survival rate than those treated with excision. Despite this, many insurance carriers do not view Mohs’...

Vitamin supplement reduces the risk of skin cancer

|Comments are Off
According to a report in the New York Times (5/14, Pollack, Subscription Publication), people who are prone to getting basal cell carcinoma and squamous cell carcinoma who take an inexpensive vitamin can reduce their chance of getting these common skin cancers. In a clinical...

NEW MELANOMA DRUG LOOKS PROMISING FOR STAGE III AND IV MELANOMA PATIENTS

|Comments are Off
51% Of Patients Benefited In Phase II Trial. Forbes (10/30, Fortonbury) reports that in a study published in Annals of Surgical Oncology, a new cancer drug, PV-10, 51% of stage III and IV melanoma patients benefited during a phase II trial, and achieved total cancer disappearance...

Drug Approved for Inoperable Melanoma

|Comments are Off
Keytruda (pembrolizumab) was finally approved for the treatment of inoperable malignant melanoma. Testing was never completed as it performed so well in the early clinical trials.